BioHarvest Sciences (NASDAQ:BHST) Issues Earnings Results, Misses Estimates By $0.05 EPS

BioHarvest Sciences (NASDAQ:BHST) issued its quarterly earnings data on Monday. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.05), Zacks reports. The company had revenue of $7.17 million for the quarter, compared to the consensus estimate of $7.24 million.

BioHarvest Sciences Trading Up 4.8 %

BHST opened at $6.49 on Wednesday. The company has a market capitalization of $106.60 million, a price-to-earnings ratio of -5.20 and a beta of 2.27. The stock has a 50 day moving average price of $5.67. BioHarvest Sciences has a 1-year low of $6.15 and a 1-year high of $7.38.

Analyst Ratings Changes

A number of research firms have recently issued reports on BHST. HC Wainwright started coverage on BioHarvest Sciences in a research note on Friday, December 6th. They issued a “buy” rating and a $14.00 price target on the stock. Maxim Group began coverage on BioHarvest Sciences in a research report on Wednesday, December 18th. They issued a “buy” rating and a $12.00 target price on the stock.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.